2 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
Follow Lymphopenia: new trials by email Literature Review of Lymphopenia trials Research Report on Lymphopenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome Romiplostim, Eltrombopag - Wiskott-Aldrich Syndrome | Phase 2 | Unknown | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 30 | 2019-11-05 | 2020-05-06 |
| A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS Patients G-CSF for Conditioning before HSCT., Plerixafor for Conditioning before HSCT. - Wiskott-Aldrich Syndrome, Hematopoietic Stem Cell Transplantation | Phase 2 | Unknown | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 30 | 2016-06-01 | 2018-12-12 |
Wiskott-Aldrich Syndrome (2) · Thrombocytopenia (1)
Blood Coagulation Disorders (2) · Blood Coagulation Disorders, Inherited (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Cytopenia (2) · Genetic Diseases, Inborn (2) · Genetic Diseases, X-Linked (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhagic Disorders (2) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2) · Leukocyte Disorders (2) · Leukopenia (2) · Primary Immunodeficiency Diseases (2)
Granulocyte Colony-Stimulating Factor (1) · eltrombopag (1) · plerixafor (1) · romiplostim (1)
Federal Research Institute of Pediatric Hematology, Oncology and Immunology (2)
Russia (2)
Alexei Maschan, Professor (1) · Dmitry Balashov (1)